Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-21

Clinical Trial Update: Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or Large Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing proton radiotherapy to radiofrequency ablation for medium to large hepatocellular carcinoma; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: UNKNOWN